AcelRx Pharmaceuticals Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (27)

Latest Posts

About This Stock More About This Stock
Research Report: AcelRx Pharmaceuticals (ACRX)
Article By: Elle Investments
Tuesday, May 26, 2020 1:12 PM EDT
Sales of sublingual sufentanil tablet Dsuvia have been slow out of the gate, but we remain very bullish on the long-term prospects.
In this article: ACRX
Read
2 Hot Biotechs With Major FDA Catalysts
Article By: TipRanks
Wednesday, October 24, 2018 4:58 AM EDT
Biotech stocks can soar or plunge depending on FDA decisions. There’s no doubt that buying ahead of PDUFA dates is a risky call.
In this article: ACRX, CPRX Also: TXMD, OCUL
Read
Biopharma Stocks Show Resilience In Yo-Yo Week
Article By: Rod Raynovich
Friday, September 16, 2016 1:44 AM EDT
Traders “whipsawed” biotech stocks but still the IBB managed to hold onto short-term gains of 10 points over the intermediate support of $280.
In this article: AGN, BMY, ACRX, IBB, AMGN, GILD, XBI, VTAE, BLUE, AERI
Read
Thursday Morning Pre-Market Insights: CNC, BBEP, FIT, ACRX
Article By: TipRanks
Thursday, July 2, 2015 9:16 AM EDT
Thursday Morning Pre-Market Insights: Centene Corp, BreitBurn Energy Partners, L.P., Fitbit Inc. and AcelRx Pharmaceuticals, Inc.
In this article: ACRX, BBEP, CNC, FIT
Read

PARTNER HEADLINES

Latest Tweets for $ACRX

No tweets yet!